RIL
SRTA

Rothschild Investment LLC’s Strata Critical Medical Inc SRTA Stock Holding History

Rothschild Investment LLC’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$481 Buy
+115
New +$554 ﹤0.01% 3140

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rothschild Investment LLC's SRTA Position: Q1 2026 in Review

Rothschild Investment LLC opened a new position in Strata Critical Medical Inc (SRTA) in Q1 2026: 115 shares worth $481. The stake represents ﹤0.01% of the portfolio and ranks #3140 among its holdings.

125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Rothschild Investment LLC held 115 shares of Strata Critical Medical Inc worth $481 as of Q1 2026.
  • Strata Critical Medical Inc was a new Rothschild Investment LLC position in Q1 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #3140 holding.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.